哲学与宗教
类型
可以朗读
语音朗读
236千字
字数
2022-09-01
发行日期
展开全部
主编推荐语
本书基于全国范围的监测数据，全面、客观、多维度及系统性地分析了我国儿童肿瘤的住院特征及流行现状。
内容简介
本年报由八章组成，第一至三章主要介绍国家儿童肿瘤监测工作政策背景、目标与任务、工作方法与内容、工作质量控制。第四和五章主要介绍本年报的统计分类、指标与分析方法、数据纳入范围及质量控制结果。
第六章描述了监测范围内我国六大区的总体及11类儿童肿瘤患儿的住院特征，包括出院人次的疾病构成、就医省份分布、次均住院费用及住院日；
第七章介绍了监测范围内我国六大区、5个年龄组和不同性别的总体及11大类儿童肿瘤新发患儿的流行特征，包括癌谱特征，以及11大类儿童肿瘤新发患者的地区分布、亚型构成、年龄/性别构成；
第八章展示了中国0～19岁儿童肿瘤发病率的估算结果，包括全国及不同性别的癌谱特征，以及11大类儿童肿瘤的不同亚型、年龄组/性别的发病率。
目录
- 版权信息
- 编 委 会
- Editorial Board
- 简 介
- Introduction
- 序
- Preface
- 前 言
- Foreword
- 致 谢
- Acknowledgment
- 第一章 国家儿童肿瘤监测工作政策背景、目标与任务
- 1 国家儿童肿瘤监测工作的政策背景
- 2 国家儿童肿瘤监测工作的总目标
- 3 国家儿童肿瘤监测工作的主要任务
- Chapter 1 Policy background，objectives，and tasks of National Pediatric Cancer Surveillance
- 1 Policy background of National Pediatric Cancer Surveillance
- 2 The overall goal of National Pediatric Cancer Surveillance
- 3 The main tasks of National Pediatric Cancer Surveillance
- 第二章 国家儿童肿瘤监测工作方法与内容
- 1 建立儿童肿瘤监测网络
- 1.1 设立儿童肿瘤监测点
- 1.2 搭建国家儿童肿瘤监测平台
- 2 开展监测信息收集工作
- 2.1 监测信息收集的组织实施
- 2.2 监测信息的收集方式
- 3 监测信息收集内容
- 3.1 监测对象
- 3.2 监测疾病
- 3.3 登记变量
- Chapter 2 Methods and contents of National Pediatric Cancer Surveillance
- 1 Establishment of pediatric cancer surveillance network
- 1.1 Establishment of pediatric cancer surveillance sites
- 1.2 Establishment of the National Platform for Pediatric Cancer Surveillance
- 2 Carrying out the collection of pediatric cancer surveillance information
- 2.1 Organization and implementation of information collection
- 2.2 Collection methods of surveillance information
- 3 Collection contents of surveillance information
- 3.1 Objects under surveillance
- 3.2 Diseases under surveillance
- 3.3 Registering variables
- 第三章 国家儿童肿瘤监测工作质量控制
- 1 资料收集阶段
- 1.1 设置病例报告卡双重审核流程
- 1.2 开展病例报告卡登记与上报培训
- 1.3 明确病例报告卡登记变量与标准
- 2 资料整理阶段
- 2.1 病例报告卡的质量控制
- 2.2 患者主索引的建立与质量控制
- Chapter 3 Quality control for work of National Pediatric Cancer Surveillance
- 1 Data collection stage
- 1.1 Setting up a double-review process of report cards
- 1.2 Training on report card registration and reporting
- 1.3 Certificating variables and standards of report card registration
- 2 Data collation stage
- 2.1 Quality control of report cards
- 2.2 Establishment and quality control of master patient index
- 第四章 统计分类、指标与分析方法
- 1 统计分类方法
- 1.1 按疾病分类
- 1.2 按地区分类
- 2 统计分析指标
- 2.1 发病率相关指标
- 2.2 住院特征相关指标
- 3 统计分析方法
- Chapter 4 Statistical classification，indicators，and analysis methods
- 1 Statistical classif ication methods
- 1.1 Classification by disease
- 1.2 Classification by region
- 2 Statistical analysis indicators
- 2.1 Incidence indicators
- 2.2 Hospitalization characteristics indicators
- 3 Statistical analysis methods
- 第五章 本年报数据介绍
- 1 数据纳入范围
- 1.1 数据来源
- 1.2 疾病范围
- 1.3 时间范围
- 2 数据质量控制结果
- 2.1 数据纳入情况
- 2.2 数据质量评价
- 3 数据分析内容
- Chapter 5 Data introduction of this annual report
- 1 Data inclusion scope
- 1.1 Data source
- 1.2 Disease scope
- 1.3 Time range
- 2 Results of data quality control
- 2.1 Data inclusion
- 2.2 Data quality evaluation
- 3 Analysis content
- 第六章 2019—2020年监测肿瘤患儿住院特征分析
- 1 2019—2020年监测肿瘤患儿住院特征分析
- 1.1 监测肿瘤患儿疾病构成
- 1.2 监测肿瘤患儿就医省份分布
- 1.3 监测肿瘤患儿住院费用分析
- 1.4 监测肿瘤患儿平均住院日分析
- 2 2019—2020年监测白血病患儿住院特征分析
- 2.1 监测白血病患儿出院人次分析
- 2.2 监测白血病患儿就医省份分布
- 2.3 监测白血病患儿住院费用分析
- 2.4 监测白血病患儿平均住院日分析
- 3 2019—2020年监测淋巴瘤患儿住院特征分析
- 3.1 监测淋巴瘤患儿出院人次分析
- 3.2 监测淋巴瘤患儿就医省份分布
- 3.3 监测淋巴瘤患儿住院费用分析
- 3.4 监测淋巴瘤患儿平均住院日分析
- 4 2019—2020年监测中枢神经系统肿瘤患儿住院特征分析
- 4.1 监测中枢神经系统肿瘤患儿出院人次分析
- 4.2 监测中枢神经系统肿瘤患儿就医省份分布
- 4.3 监测中枢神经系统肿瘤患儿住院费用分析
- 4.4 监测中枢神经系统肿瘤患儿平均住院日分析
- 5 2019—2020年监测神经母细胞瘤和其他周围神经细胞肿瘤患儿住院特征分析
- 5.1 监测神经母细胞瘤和其他周围神经细胞肿瘤患儿出院人次分析
- 5.2 监测神经母细胞瘤和其他周围神经细胞肿瘤患儿就医省份分布
- 5.3 监测神经母细胞瘤和其他周围神经细胞肿瘤患儿住院费用分析
- 5.4 监测神经母细胞瘤和其他周围神经细胞肿瘤患儿平均住院日分析
- 6 2019—2020年监测视网膜母细胞瘤患儿住院特征分析
- 6.1 监测视网膜母细胞瘤患儿出院人次分析
- 6.2 监测视网膜母细胞瘤患儿就医省份分布
- 6.3 监测视网膜母细胞瘤患儿住院费用分析
- 6.4 监测视网膜母细胞瘤患儿平均住院日分析
- 7 2019—2020年监测肾肿瘤患儿住院特征分析
- 7.1 监测肾肿瘤患儿出院人次分析
- 7.2 监测肾肿瘤患儿就医省份分布
- 7.3 监测肾肿瘤患儿住院费用分析
- 7.4 监测肾肿瘤患儿平均住院日分析
- 8 2019—2020年监测肝肿瘤患儿住院特征分析
- 8.1 监测肝肿瘤患儿出院人次分析
- 8.2 监测肝肿瘤患儿就医省份分布
- 8.3 监测肝肿瘤患儿住院费用分析
- 8.4 监测肝肿瘤患儿平均住院日分析
- 9 2019—2020年监测恶性骨肿瘤患儿住院特征分析
- 9.1 监测恶性骨肿瘤患儿出院人次分析
- 9.2 监测恶性骨肿瘤患儿就医省份分布
- 9.3 监测恶性骨肿瘤患儿住院费用分析
- 9.4 监测恶性骨肿瘤患儿平均住院日分析
- 10 2019—2020年监测软组织肉瘤患儿住院特征分析
- 10.1 监测软组织肉瘤患儿出院人次分析
- 10.2 监测软组织肉瘤患儿就医省份分布
- 10.3 监测软组织肉瘤患儿住院费用分析
- 10.4 监测软组织肉瘤患儿平均住院日分析
- 11 2019—2020年监测生殖细胞肿瘤患儿住院特征分析
- 11.1 监测生殖细胞肿瘤患儿出院人次分析
- 11.2 监测生殖细胞肿瘤患儿就医省份分布
- 11.3 监测生殖细胞肿瘤患儿住院费用分析
- 11.4 监测生殖细胞肿瘤患儿平均住院日分析
- 12 2019—2020年监测恶性上皮肿瘤和黑色素瘤患儿住院特征分析
- 12.1 监测恶性上皮肿瘤和黑色素瘤患儿出院人次分析
- 12.2 监测恶性上皮肿瘤和黑色素瘤患儿就医省份分布
- 12.3 监测恶性上皮肿瘤和黑色素瘤患儿住院费用分析
- 12.4 监测恶性上皮肿瘤和黑色素瘤患儿平均住院日分析
- Chapter 6 Analysis of hospitalization characteristics among children with cancer in surveillance system in 2019-2020
- 1 Analysis of hospitalization characteristics among children with cancer in surveillance system in 2019-2020
- 1.1 Disease composition of discharges among children with cancer in surveillance system
- 1.2 Distribution of provincial-level regions visited by children with cancer in surveillance system
- 1.3 Analysis of hospitalization expenses of children with cancer in surveillance system
- 1.4 Analysis of the average length of hospitalization of children with cancer in surveillance system
- 2 Analysis of hospitalization characteristics among children with leukemias in surveillance system in 2019-2020
- 2.1 Analysis of discharges among children with leukemias in surveillance system
- 2.2 Distribution of provincial-level regions visited by children with leukemias in surveillance system
- 2.3 Analysis of hospitalization expenses of children with leukemias in surveillance system
- 2.4 Analysis of the average length of hospitalization of children with leukemias in surveillance system
- 3 Analysis of hospitalization characteristics among children with lymphomas in surveillance system in 2019-2020
- 3.1 Analysis of discharges among children with lymphomas in surveillance system
- 3.2 Distribution of provincial-level regions visited by children with lymphomas in surveillance system
- 3.3 Analysis of hospitalization expenses of children with lymphomas in surveillance system
- 3.4 Analysis of the average length of hospitalization of children with lymphomas in surveillance system
- 4 Analysis of hospitalization characteristics among children with CNS tumors in surveillance system in 2019-2020
- 4.1 Analysis of discharges among children with CNS tumors in surveillance system
- 4.2 Distribution of provincial-level regions visited by children with CNS tumors in surveillance system
- 4.3 Analysis of hospitalization expenses of children with CNS tumors in surveillance system
- 4.4 Analysis of the average length of hospitalization of children with CNS tumors in surveillance system
- 5 Analysis of hospitalization characteristics among children with neuroblastoma and PNS in surveillance systerm in 2019-2020
- 5.1 Analysis of discharges among children with neuroblastoma and PNS in surveillance system
- 5.2 Distribution of provincial-level regions visited by children with neuroblastoma and PNS in surveillance system
- 5.3 Analysis of hospitalization expenses of children with neuroblastoma and PNS in surveillance system
- 5.4 Analysis of the average length of hospitalization of children with neuroblastoma and PNS in surveillance system
- 6 Analysis of hospitalization characteristics among children with retinoblastoma in surveillance system in 2019-2020
- 6.1 Analysis of discharges among children with retinoblastoma in surveillance system
- 6.2 Distribution of provincial-level regions visited by children with retinoblastoma in surveillance system
- 6.3 Analysis of hospitalization expenses of children with retinoblastoma in surveillance system
- 6.4 Analysis of the average length of hospitalization of children with retinoblastoma in surveillance system
- 7 Analysis of hospitalization characteristics among children with renal tumors in surveillance system in 2019-2020
- 7.1 Analysis of discharges among children with renal tumors in surveillance system
- 7.2 Distribution of provincial-level regions visited by children with renal tumors in surveillance system
- 7.3 Analysis of hospitalization expenses of children with renal tumors in surveillance system
- 7.4 Analysis of the average length of hospitalization of children with renal tumors in surveillance system
- 8 Analysis of hospitalization characteristics among children with hepatic tumors in surveillance system in 2019-2020
- 8.1 Analysis of discharges among children with hepatic tumors in surveillance system
- 8.2 Distribution of provincial-level regions visited by children with hepatic tumors in surveillance system
- 8.3 Analysis of hospitalization expenses of children with hepatic tumors in surveillance system
- 8.4 Analysis of the average length of hospitalization of children with hepatic tumors in surveillance system
- 9 Analysis of hospitalization characteristics among children with malignant bone tumors in surveillance system in 2019-2020
- 9.1 Analysis of discharges among children with malignant bone tumors in surveillance system
- 9.2 Distribution of provincial-level regions visited by children with malignant bone tumors in surveillance system
- 9.3 Analysis of hospitalization expenses of children with malignant bone tumors in surveillance system
- 9.4 Analysis of the average length of hospitalization of children with malignant bone tumors in surveillance system
- 10 Analysis of hospitalization characteristics among children with soft tissue sarcomas in surveillance system in 2019-2020
- 10.1 Analysis of discharges among children with soft tissue sarcomas in surveillance system
- 10.2 Distribution of provincial-level regions visited by children with soft tissue sarcomas in surveillance system
- 10.3 Analysis of hospitalization expenses of children with soft tissue sarcomas in surveillance system
- 10.4 Analysis of the average length of hospitalization of children with soft tissue sarcomas in surveillance system
- 11 Analysis of hospitalization characteristics among children with germ cell tumors in surveillance system in 2019-2020
- 11.1 Analysis of discharges among children with germ cell tumors in surveillance system
- 11.2 Distribution of provincial-level regions visited by children with germ cell tumors in surveillance system
- 11.3 Analysis of hospitaliza tion expenses of children with germ cell tumors in surveillance system
- 11.4 Analysis of the average length of hospitalization of children with germ cell tumors in surveillance system
- 12 Analysis of hospitalization characteristics among children with malignant epithelial neoplasms and melanomas in surveillance system in 2019-2020
- 12.1 Analysis of discharges among children with malignant epithelial neoplasms and melanomas in surveillance system
- 12.2 Distribution of provincial-level regions visited by children with malignant epithelial neoplasms and melanomas in surveillance system
- 12.3 Analysis of hospitalization expenses of children with malignant epithelial neoplasms and melanomas in surveillance system
- 12.4 Analysis of the average length of hospitalization of children with malignant epithelial neoplasms and melanomas in surveillance system
- 第七章 2019—2020年监测新发肿瘤患儿流行特征分析
- 1 2019—2020年监测新发肿瘤患儿流行特征分析
- 1.1 各地区新发肿瘤患儿的癌种分布
- 1.2 各地区新发肿瘤患儿的年龄/性别构成
- 2 2019—2020年监测新发白血病患儿流行特征分析
- 2.1 新发白血病患儿的地区分布
- 2.2 新发白血病患儿的亚型构成
- 2.3 各地区新发白血病患儿的年龄/性别构成
- 3 2019—2020年监测新发淋巴瘤患儿流行特征分析
- 3.1 新发淋巴瘤患儿的地区分布
- 3.2 新发淋巴瘤患儿的亚型构成
- 3.3 各地区新发淋巴瘤患儿的年龄/性别构成
- 4 2019—2020年监测新发中枢神经系统肿瘤患儿流行特征分析
- 4.1 新发中枢神经系统肿瘤患儿的地区分布
- 4.2 新发中枢神经系统肿瘤患儿的亚型构成
- 4.3 各地区新发中枢神经系统肿瘤患儿的年龄/性别构成
- 5 2019—2020年监测新发神经母细胞瘤和其他周围神经细胞肿瘤患儿流行特征分析
- 5.1 新发神经母细胞瘤和其他周围神经细胞肿瘤患儿的地区分布
- 5.2 新发神经母细胞瘤和其他周围神经细胞肿瘤患儿的亚型构成
- 5.3 各地区新发神经母细胞瘤和其他周围神经细胞肿瘤患儿的年龄/性别构成
- 6 2019—2020年监测新发视网膜母细胞瘤患儿流行特征分析
- 6.1 新发视网膜母细胞瘤患儿的地区分布
- 6.2 各地区新发视网膜母细胞瘤患儿的年龄/性别构成
- 7 2019—2020年监测新发肾肿瘤患儿流行特征分析
- 7.1 新发肾肿瘤患儿的地区分布
- 7.2 新发肾肿瘤患儿的亚型构成
- 7.3 各地区新发肾肿瘤患儿的年龄/性别构成
- 8 2019—2020年监测新发肝肿瘤患儿流行特征分析
- 8.1 新发肝肿瘤患儿的地区分布
- 8.2 新发肝肿瘤患儿的亚型构成
- 8.3 各地区新发肝肿瘤患儿的年龄/性别构成
- 9 2019—2020年监测新发恶性骨肿瘤患儿流行特征分析
- 9.1 新发恶性骨肿瘤患儿的地区分布
- 9.2 新发恶性骨肿瘤患儿的亚型构成
- 9.3 各地区新发恶性骨肿瘤患儿的年龄/性别构成
- 10 2019—2020年监测新发软组织肉瘤患儿流行特征分析
- 10.1 新发软组织肉瘤患儿的地区分布
- 10.2 新发软组织肉瘤患儿的亚型构成
- 10.3 各地区新发软组织肉瘤患儿的年龄/性别构成
- 11 2019—2020年监测新发生殖细胞肿瘤患儿流行特征分析
- 11.1 新发生殖细胞肿瘤患儿的地区分布
- 11.2 新发生殖细胞肿瘤患儿的亚型构成
- 11.3 各地区新发生殖细胞肿瘤患儿的年龄/性别构成
- 12 2019—2020年监测新发恶性上皮肿瘤和黑色素瘤患儿流行特征分析
- 12.1 新发恶性上皮肿瘤和黑色素瘤患儿的地区分布
- 12.2 新发恶性上皮肿瘤和黑色素瘤患儿的亚型构成
- 12.3 各地区新发恶性上皮肿瘤和黑色素瘤患儿的年龄/性别构成
- Chapter 7 Analysis of epidemiological characteristics of new cases among children with cancer in surveillance system in 2019-2020
- 1 Analysis of epidemiological characteristics of new cases among children with cancer in surveillance system in 2019-2020
- 1.1 Distribution of cancer groups of new cases among children with cancer in different regions
- 1.2 Age/sex composition of new cases among children with cancer in different regions
- 2 Analysis of epidemiological characteristics of new cases among children with leukemias in surveillance system in 2019-2020
- 2.1 Regional distribution of new cases among children with leukemias
- 2.2 Subgroup composition of new cases among children with leukemias
- 2.3 Age/sex composition of new cases among children with leukemias in different regions
- 3 Analysis of epidemiological characteristics of new cases among children with lymphomas in surveillance system in 2019-2020
- 3.1 Regional distribution of new cases among children with lymphomas
- 3.2 Subgroup composition of new cases among children with lymphomas
- 3.3 Age/sex composition of new cases among children with lymphomas in different regions
- 4 Analysis of epidemiological characteristics of new cases among children with CNS tumors in surveillance system in 2019-2020
- 4.1 Regional distribution of new cases among children with CNS tumors
- 4.2 Subgroup composition of new cases among children with CNS tumors
- 4.3 Age/sex composition of new cases among children with CNS tumors in different regions
- 5 Analysis of epidemiological characteristics of new cases among children with neuroblastoma and PNS in surveillance system in 2019-2020
- 5.1 Regional distribution of new cases among children with neuroblastoma and PNS
- 5.2 Subgroup composition of new cases among children with neuroblastoma and PNS
- 5.3 Age/sex composition of new cases among children with neuroblastoma and PNS in different regions
- 6 Analysis of epidemiological characteristics of new cases among children with retinoblastoma in surveillance system in 2019-2020
- 6.1 Regional distribution of new cases among children with retinoblastoma
- 6.2 Age/sex composition of new cases among children with retinoblastoma in different regions
- 7 Analysis of epidemiological characteristics of new cases among children with renal tumors in surveillance system in 2019-2020
- 7.1 Regional distribution of new cases among children with renal tumors
- 7.2 Subgroup composition of new cases among children with renal tumors
- 7.3 Age/sex composition of new cases among children with renal tumors in different regions
- 8 Analysis of epidemiological characteristics of new cases among children with hepatic tumors in surveillance system in 2019-2020
- 8.1 Regional distribution of new cases among children with hepatic tumors
- 8.2 Subgroup composition of new cases among children with hepatic tumors
- 8.3 Age/sex composition of new cases among children with hepatic tumors in different regions
- 9 Analysis of epidemiological characteristics of new cases among children with malignant bone tumors in surveillance system in 2019-2020
- 9.1 Regional distribution of new cases among children with malignant bone tumors
- 9.2 Subgroup composition of new cases among children with malignant bone tumors
- 9.3 Age/sex composition of new cases among children with malignant bone tumors in different regions
- 10 Analysis of epidemiological characteristics of new cases among children with soft tissue sarcomas in surveillance system in 2019-2020
- 10.1 Regional distribution of new cases among children with soft tissue sarcomas
- 10.2 Subgroup composition of new cases among children with soft tissue sarcomas
- 10.3 Age/sex composition of new cases among children with soft tissue sarcomas in different regions
- 11 Analysis of epidemiological characteristics of new cases among children with germ cell tumors in surveillance system in 2019-2020
- 11.1 Regional distribution of new cases among children with germ cell tumors
- 11.2 Subgroup composition of new cases among children with germ cell tumors
- 11.3 Age/sex composition of new cases among children with germ cell tumors in different regions
- 12 Analysis of epidemiological characteristics of new cases among children with malignant epithelial neoplasms and melanomas in surveillance system in 2019-2020
- 12.1 Regional distribution of new cases among children with malignant epithelial neoplasms and melanomas
- 12.2 Subgroup composition of new cases among children with malignant epithelial neoplasms and melanomas
- 12.3 Age/sex composition of new cases among children with malignant epithelial neoplasms and melanomas in different regions
- 第八章 2019—2020年中国儿童肿瘤的估算发病率
- 1 2019—2020年中国儿童肿瘤发病率
- 1.1 中国儿童肿瘤发病率
- 1.2 中国儿童肿瘤的年龄/性别发病率
- 1.3 中国儿童肿瘤的发病率癌谱
- 2 2019—2020年中国儿童白血病发病率
- 2.1 中国儿童白血病发病率
- 2.2 中国儿童白血病的年龄/性别发病率
- 2.3 中国儿童白血病各亚型发病率
- 3 2019—2020年中国儿童淋巴瘤发病率
- 3.1 中国儿童淋巴瘤发病率
- 3.2 中国儿童淋巴瘤的年龄/性别发病率
- 3.3 中国儿童淋巴瘤各亚型发病率
- 4 2019—2020年中国儿童中枢神经系统肿瘤发病率
- 4.1 中国儿童中枢神经系统肿瘤发病率
- 4.2 中国儿童中枢神经系统肿瘤的年龄/性别发病率
- 4.3 中国儿童中枢神经系统肿瘤各亚型发病率
- 5 2019—2020年中国儿童神经母细胞瘤和其他周围神经细胞肿瘤发病率
- 5.1 中国儿童神经母细胞瘤和其他周围神经细胞肿瘤发病率
- 5.2 中国儿童神经母细胞瘤和其他周围神经细胞肿瘤的年龄/性别发病率
- 5.3 中国儿童神经母细胞瘤和其他周围神经细胞肿瘤各亚型发病率
- 6 2019—2020年中国儿童视网膜母细胞瘤发病率
- 6.1 中国儿童视网膜母细胞瘤发病率
- 6.2 中国儿童视网膜母细胞瘤的年龄/性别发病率
- 7 2019—2020年中国儿童肾肿瘤发病率
- 7.1 中国儿童肾肿瘤发病率
- 7.2 中国儿童肾肿瘤的年龄/性别发病率
- 7.3 中国儿童肾肿瘤各亚型发病率
- 8 2019—2020年中国儿童肝肿瘤发病率
- 8.1 中国儿童肝肿瘤发病率
- 8.2 中国儿童肝肿瘤的年龄/性别发病率
- 8.3 中国儿童肝肿瘤各亚型发病率
- 9 2019—2020年中国儿童恶性骨肿瘤发病率
- 9.1 中国儿童恶性骨肿瘤发病率
- 9.2 中国儿童恶性骨肿瘤的年龄/性别发病率
- 9.3 中国儿童恶性骨肿瘤各亚型发病率
- 10 2019—2020年中国儿童软组织肉瘤发病率
- 10.1 中国儿童软组织肉瘤发病率
- 10.2 中国儿童软组织肉瘤的年龄/性别发病率
- 10.3 中国儿童软组织肉瘤各亚型发病率
- 11 2019—2020年中国儿童生殖细胞肿瘤发病率
- 11.1 中国儿童生殖细胞肿瘤发病率
- 11.2 中国儿童生殖细胞肿瘤的年龄/性别发病率
- 11.3 中国儿童生殖细胞肿瘤各亚型发病率
- 12 2019—2020年中国儿童恶性上皮肿瘤和黑色素瘤发病率
- 12.1 中国儿童恶性上皮肿瘤和黑色素瘤发病率
- 12.2 中国儿童恶性上皮肿瘤和黑色素瘤的年龄/性别发病率
- 12.3 中国儿童恶性上皮肿瘤和黑色素瘤各亚型发病率
- Chapter 8 Estimated incidence rate of childhood cancer in China，2019-2020
- 1 Incidence rates of cancer among children in China，2019-2020
- 1.1 Overall incidence rates of cancer among children in China
- 1.2 Age/sex incidence rates of cancer among children in China
- 1.3 Cancer incidence spectrum among children in China
- 2 Incidence rates of leukemias among children in China，2019-2020
- 2.1 Incidence rates of leukemias among children in China
- 2.2 Age/sex incidence rates of leukemias among children in China
- 2.3 Incidence rates of leukemias subgroups among children in China
- 3 Incidence rates of lymphomas among children in China，2019-2020
- 3.1 Incidence rates of lymphomas among children in China
- 3.2 Age/sex incidence rates of lymphomas among children in China
- 3.3 Incidence rates of lymphomas subgroups among children in China
- 4 Incidence rates of CNS tumors among children in China，2019-2020
- 4.1 Incidence rates of CNS tumors among children in China
- 4.2 Age/sex incidence rates of CNS tumors among children in China
- 4.3 Incidence rates of CNS tumors subgroups among children in China
- 5 Incidence rates of neuroblastoma and PNS among children in China，2019-2020
- 5.1 Incidence rates of neuroblastoma and PNS among children in China
- 5.2 Age/sex incidence rates of neuroblastoma and PNS among children in China
- 5.3 Incidence rates of neuroblastoma and PNS subgroups among children in China
- 6 Incidence rates of retinoblastoma among children in China，2019-2020
- 6.1 Incidence rates of retinoblastoma among children in China
- 6.2 Age/sex incidence rates of retinoblastoma among children in China
- 7 Incidence rates of renal tumors among children in China，2019-2020
- 7.1 Incidence rates of renal tumors among children in China
- 7.2 Age/sex incidence rates of renal tumors among children in China
- 7.3 Incidence rates of renal tumors subgroups among children in China
- 8 Incidence rates of hepatic tumors among children in China，2019-2020
- 8.1 Incidence rates of hepatic tumors among children in China
- 8.2 Age/sex incidence rates of hepatic tumors among children in China
- 8.3 Incidence rates of hepatic tumors subgroups among children in China
- 9 Incidence rates of malignant bone tumors among children in China，2019-2020
- 9.1 Incidence rates of malignant bone tumors among children in China
- 9.2 Age/sex incidence rates of malignant bone tumors among children in China
- 9.3 Incidence rates of malignant bone tumors subgroups among children in China
- 10 Incidence rates of soft tissue sarcomas among children in China，2019-2020
- 10.1 Incidence rates of soft tissue sarcomas among children in China
- 10.2 Age/sex incidence rates of soft tissue sarcomas among children in China
- 10.3 Incidence rates of soft tissue sarcomas subgroups among children in China
- 11 Incidence rates of germ cell tumors among children in China，2019-2020
- 11.1 Incidence rates of germ cell tumors among children in China
- 11.2 Age/sex incidence rates of germ cell tumors among children in China
- 11.3 Incidence rates of germ cell tumors subgroups among children in China
- 12 Incidence rates of malignant epithelial neoplasms and melanomas among children in China，2019-2020
- 12.1 Incidence rates of malignant epithelial neoplasms and melanomas among children in China
- 12.2 Age/sex incidence rates of malignant epithelial neoplasms and melanomas among children in China
- 12.3 Incidence rates of malignant epithelial neoplasms and melanomas subgroups among children in China
- 附录 监测疾病目录 Appendix Catalog of diseases under surveillance
展开全部
评分及书评
尚无评分
目前还没人评分
出版方
人民卫生出版社
人民卫生出版社是中华人民共和国国家卫生健康委员会直属的中央级医药卫生专业出版社，成立于1953年6月1日，是中国规模大、实力强、出版品种多的医学出版机构。1993年被中宣部、新闻出版署评为中国首批优秀出版社。
